Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kedrion fibrin sealant in middle ear microsurgery for chronic otitis
2010-023991-15Phase 2Completed
- Sponsor
- Kedrion Biopharma
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of fibrin sealant in chronic otitis media (COM) (2 arms), sponsored by Kedrion Biopharma. Primary endpoint: Primary efficacy endpoint. Started Dec 2011; status: completed.
02
Drugs
fibrin sealant
03
Conditions
chronic otitis media (COM)
Beyond the preview
Go deeper on 2010-023991-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023991-15.